Literature DB >> 12040071

Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine.

Paul Vezina1, Daniel S Lorrain, Gretchen M Arnold, Jennifer D Austin, Nobuyoshi Suto.   

Abstract

Stimulant drugs such as amphetamine are readily self-administered by humans and laboratory animals by virtue of their actions on dopamine (DA) neurons of the midbrain. Repeated exposure to this drug systemically or exclusively in the cell body region of these neurons in the ventral tegmental area (VTA) leads to long-lasting changes in dopaminergic function that can be assessed by increased locomotor activity and enhanced DA overflow in the nucleus accumbens (NAcc) after re-exposure to the drug. Three experiments were conducted to evaluate the possibility that this enduring sensitized reactivity underlies compulsive drug self-administration. In all experiments, rats were pre-exposed to amphetamine and, starting 10 d later, their intravenous self-administration of the drug was assessed. In the first experiment, rats previously exposed to amphetamine systemically or exclusively in the VTA subsequently worked harder than untreated animals to obtain the drug when the work required to obtain successive infusions was increased progressively. In the second experiment, this progressively increasing workload was found to decrease the magnitude of amphetamine-induced DA overflow observed with successive infusions until responding ceased. Rats previously exposed to amphetamine were more resistant to this decline and more apt to maintain responding. Finally, in experiment three, a noncontingent priming injection of the drug produced a greater NAcc DA response and a greater parallel increase in lever pressing in drug compared with saline pre-exposed rats. Together, these results demonstrate a direct relation between drug-induced sensitization of midbrain dopamine neuron reactivity and the excessive pursuit and self-administration of an abused substance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040071      PMCID: PMC6758806          DOI: 20026447

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

1.  The effect of previous exposure to amphetamine on drug-induced locomotion and self-administration of a low dose of the drug.

Authors:  P Vezina; P J Pierre; D S Lorrain
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

2.  D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug.

Authors:  P J Pierre; P Vezina
Journal:  Psychopharmacology (Berl)       Date:  1998-07       Impact factor: 4.530

3.  Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone.

Authors:  F Rougé-Pont; V Deroche; M Le Moal; P V Piazza
Journal:  Eur J Neurosci       Date:  1998-12       Impact factor: 3.386

Review 4.  Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.

Authors:  P W Kalivas; J Stewart
Journal:  Brain Res Brain Res Rev       Date:  1991 Sep-Dec

5.  Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants.

Authors:  J Stewart; H de Wit; R Eikelboom
Journal:  Psychol Rev       Date:  1984-04       Impact factor: 8.934

6.  Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices.

Authors:  L Kantor; M E Gnegy
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

7.  The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum.

Authors:  A M Gray; S M Rawls; T S Shippenberg; J F McGinty
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

8.  Individual differences in behavioral measures: correlations with nucleus accumbens dopamine measured by microdialysis.

Authors:  C W Bradberry; R J Gruen; C W Berridge; R H Roth
Journal:  Pharmacol Biochem Behav       Date:  1991-08       Impact factor: 3.533

9.  Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions.

Authors:  M S Hooks; G H Jones; B J Liem; J B Justice
Journal:  Pharmacol Biochem Behav       Date:  1992-11       Impact factor: 3.533

10.  Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration.

Authors:  A Valadez; S Schenk
Journal:  Pharmacol Biochem Behav       Date:  1994-01       Impact factor: 3.533

View more
  78 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

2.  A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism.

Authors:  Joseph A Kim; Kelly A Pollak; Gregory O Hjelmstad; Howard L Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

3.  A progressive ratio schedule of self-stimulation testing in rats reveals profound augmentation of d-amphetamine reward by food restriction but no effect of a "sensitizing" regimen of d-amphetamine.

Authors:  Soledad Cabeza de Vaca; Lisa L Krahne; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2004-02-20       Impact factor: 4.530

Review 4.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

5.  Sensitizing regimens of (+/-)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat.

Authors:  K T Ball; C L Wellman; E Fortenberry; G V Rebec
Journal:  Neuroscience       Date:  2009-02-21       Impact factor: 3.590

6.  Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study.

Authors:  Joyce Colussi-Mas; Stefanie Geisler; Luc Zimmer; Daniel S Zahm; Anne Bérod
Journal:  Eur J Neurosci       Date:  2007-08       Impact factor: 3.386

7.  Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats.

Authors:  Christopher M Lack; Sara R Jones; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

Review 8.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

9.  Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.

Authors:  Andrew M Farrar; Mariana Pereira; Francisco Velasco; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

10.  Stress and Rodent Models of Drug Addiction: Role of VTA-Accumbens-PFC-Amygdala Circuit.

Authors:  Jasmine J Yap; Klaus A Miczek
Journal:  Drug Discov Today Dis Models       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.